<DOC>
	<DOC>NCT00303602</DOC>
	<brief_summary>This study is testing if under the tongue olanzapine for schizophrenia, related psychosis, schizoaffective disorder or bipolar disorder will have less weight gain than olanzapine that is swallowed, in patients who are already gaining weight on olanzapine.</brief_summary>
	<brief_title>Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Inclusion Criteria (Patients must): Be at least 18 years old Have gained weight while taking olanzapine Be able to visit the doctor's office seven times over 4 months (17 weeks) Exclusion Criteria (Patients must NOT): Have started a weight loss program within the last 8 weeks Have an illness that might affect patient's weight during the study Have an allergy to phenylalanine, mannitol or saccharine Be taking any medication (except for olanzapine) that might affect patient's weight</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>